Find Academic Supervisors

Brent HanksView profile

Associate Professor

• Cancer Immunotherapy
• Tumor Immunology
• Immune Evasion Mechanisms
• +5 more

Brent Hanks, MD, PhD is an Associate Professor in the Department of Medicine at the University of North Carolina School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center. He functions as a laboratory-based physician-scientist with clinical responsibilities managing advanced skin cancer patients and those with upper gastrointestinal malignancies. Dr. Hanks leads the Hanks Lab, which focuses on understanding tumor-mediated immune evasion mechanisms and developing strategies to overcome immunotherapy resistance. His research spans tumor-intrinsic mechanisms of immune evasion, tumor-driven manipulation of dendritic cell functionality, and the role of tumor-mediated innate training in immunotherapy resistance and associated toxicities. His work integrates transgenic mouse tumor models, clinical specimens, and bioinformatic approaches to investigate adaptive immunotherapy resistance, dendritic cell tolerization in the tumor microenvironment, EMT-associated tumor immune evasion, and mechanisms contributing to immunotherapy-associated toxicities. This research program aims to translate fundamental biochemical and metabolic pathway discoveries into early-phase clinical trials. Dr. Hanks' scientific contributions have been recognized with numerous prestigious awards including election to the American Society of Clinical Investigation (ASCI) in 2024, the V Foundation 30th Anniversary Gala Therapy Resistance Award, and multiple Young Investigator Awards from major cancer research organizations. His laboratory team includes research faculty, postdoctoral associates, graduate students, and research technicians working collaboratively to advance cancer immunotherapy. The lab has active recruitment for additional postdoctoral associates and graduate students interested in tumor immunology and immunotherapy research.

Caroline MitchellView profile

Associate Professor

• vaginal microbiome
• bacterial vaginosis
• women's reproductive health
• +5 more

Caroline Mitchell, MD, MPH is an Associate Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a faculty member in the Vincent Center for Reproductive Biology at Massachusetts General Hospital. She serves as the Director of the Vulvovaginal Disorders Program at MGH, where she sees patients with complex vulvovaginal disorders and recurrent vaginal infections. Dr. Mitchell's research focuses on the vaginal microbiome's role in women's reproductive health. Dr. Mitchell earned her undergraduate degree from Harvard College with a concentration in Women's Studies, followed by two years in the Peace Corps in Southern Africa as a high school science teacher. She completed medical school at Harvard Medical School and her OB/GYN residency training along with an MPH at the University of Washington in Seattle. After seven years on faculty at the University of Washington, she returned to Boston and Massachusetts General Hospital in 2014. Dr. Mitchell's research centers on understanding how vaginal microbes influence reproductive health and disease. Her lab conducts clinical studies, translational analyses, and bench experiments to identify key pathways in host-microbe interactions. The lab's work includes multiple ongoing clinical trials such as MOTIF (Modifying Organisms Transvaginally in Females), VIBRANT, THRIVE, and RituxiVag, focusing on vaginal microbiome transplants, HPV persistence, and the relationship between vaginal immunity and microbiome. Analysis of Dr. Mitchell's recent publications reveals a strong focus on the vaginal microbiome's role in women's health across different life stages. Her work spans basic science investigations of host-microbe interactions, clinical trials of microbiome-based therapies, and epidemiological studies of vaginal health conditions. Key themes include bacterial vaginosis, menopausal vaginal health, HPV persistence, and the development of novel microbiome-based interventions. Dr. Mitchell has received significant research funding from prestigious organizations including the NIH, Doris Duke Foundation, Bill & Melinda Gates Foundation, American Association of Obstetricians & Gynecologists Fund, and the MGH Claflin Award. She is an active member of the Vaginal Microbiome Research Consortium. Dr. Mitchell leads the Mitchell Lab, which includes several researchers working on various aspects of vaginal microbiome research. Her lab maintains close collaborations with the Kwon Lab at the Ragon Institute and participates in the MsFlash menopause research network. The lab's work bridges basic science, clinical research, and patient care to develop novel interventions for improving women's reproductive health.

• Industrial Biotechnology
• Systems Biology
• Environmental Biotechnology
• +5 more

Eugénio C. Ferreira is a Full Professor at the Department of Biological Engineering within the School of Engineering at the University of Minho. From December 2019 to February 2025, he served as Vice-Rector for Research & Innovation, overseeing the university's research strategy, innovation ecosystem, and international collaborations. He has held numerous leadership positions including President of the Board of Directors of TECMINHO (2020-2025), Vice-President of CENTI – Centre for Nanotechnology and Smart Materials (2022-2025), and Director of the Centre of Biological Engineering (2016-2020), a research unit with over 400 researchers where he leads the BIOSYSTEMS research group focused on Bioprocess Engineering and Computational Biosystems. Professor Ferreira's research expertise centers on Process Systems Engineering in Biotechnological, Chemical and Environmental Applications with emphasis on Modeling, Monitoring, and Control of Bioprocesses; Systems Biology, Bioinformatics, and Metabolic Engineering; and Image Analysis and Chemometrics in Environmental Biotechnology. His work bridges fundamental research with practical applications in industrial biotechnology, wastewater treatment, and environmental monitoring. He has published over 200 international refereed papers and book chapters, in addition to 13 books and more than 325 conference papers and communications. His recent publications demonstrate a strong focus on advanced wastewater treatment technologies, particularly aerobic granular sludge systems, with applications for removing pharmaceuticals, microplastics, and other contaminants. His research increasingly integrates computational modeling, image analysis, and systems biology approaches to optimize bioprocesses. He has made significant contributions to genome-scale metabolic modeling and its applications in industrial biotechnology. Professor Ferreira has held extensive leadership roles in academic governance, serving as a member of the Portuguese Academy of Engineering, Counselor Member at the General Council of the University of Minho, Chair of the Chemical & Biological Engineering Section of the Portuguese Engineers Institution (2010-2013), and General-Secretary of the Portuguese Society of Biotechnology (2004-2019). He has coordinated numerous research projects funded by national and European agencies and has served on editorial boards of several prestigious journals including Frontiers in Biotechnology and Bioengineering. His research group BIOSYSTEMS has secured substantial funding for projects related to bioprocess engineering, wastewater treatment, and systems biology. He has directed multiple PhD and Master's programs, including the PhD Program in Bioengineering under the MIT Portugal Program and the Master's Program in Environmental Management. His leadership extends to national and international scientific organizations, where he has influenced research policy and educational standards in biotechnology and chemical engineering.

Alan SchulmanView profile

Research Professor

• Plant Biology
• Genetics
• Molecular Biology
• +5 more

Alan Schulman is a Research Professor and Research Director at the Institute of Biotechnology within the Faculty of Biological and Environmental Sciences at the University of Helsinki. He serves as a supervisor in three doctoral programs: Integrative Life Science, Sustainable Use of Renewable Natural Resources, and Plant Sciences. His work is centered at the Viikki Plant Science Centre (ViPS), where he leads significant research initiatives in plant genomics and biotechnology. Dr. Schulman earned his Ph.D. in Cell and Developmental Biology from Yale University (1979-1986) and his B.Sc. in Botany from Duke University (1975-1979). He also holds a position as Professor at the Natural Resources Institute Finland, Green Technology Unit VITE, since 2001. His research spans multiple areas of plant science with a focus on plant genomics, crop improvement, and the application of biotechnology in agriculture. Dr. Schulman's work addresses critical challenges in food security, plant disease resistance, and adaptation to climate change. His expertise encompasses plant genetics, molecular biology, and the regulatory aspects of genetically modified organisms. Recent research has particularly emphasized genomic approaches to improve crops like faba bean, barley, oat, and strawberry, with applications in disease resistance, nutritional quality, and environmental adaptation. Dr. Schulman's extensive publication record reflects his leadership in plant genomics and biotechnology. His recent work demonstrates a strong focus on the intersection of genomic technologies, crop improvement, and regulatory science, with particular attention to how new genomic techniques can address agricultural challenges while navigating complex regulatory landscapes. His research bridges fundamental plant science with practical applications for sustainable agriculture. Knight, First Class, Order of the Lion of Finland (2010) Marquis Who's Who in the World (2010) Dr. Schulman actively mentors doctoral students across multiple programs and leads significant research projects funded by the Ministry of Agriculture and Forestry, the Academy of Finland, and other sources. His current projects include Schulman MMM 2022-2026, ViPS: Viikki Plant Science Centre, NaPPI (National Plant Phenotyping Infrastructure), ProFaba (focusing on faba bean breeding), and Papugeno (genomic tools for faba bean improvement). These projects address critical challenges in sustainable protein production, crop resilience, and advanced genomic technologies for plant improvement. As a Principal Investigator in the Viikki Plant Science Centre, Dr. Schulman works within a collaborative research environment that brings together experts across plant sciences. His research group focuses on applying genomic technologies to solve practical problems in crop improvement, with particular expertise in molecular marker development, genome analysis, and the application of new breeding techniques.

Ranjeet Singh MahlaView profile

Researcher

• Immunology
• Virology
• B cell biology
• +5 more

Ranjeet Singh Mahla is a Researcher at Fred Hutchinson Cancer Center's Vaccine and Infectious Disease Division, specializing in B cell immunology within the Corey Lab of the Infectious Disease Sciences Program. His work bridges experimental virology and computational biology to advance infectious disease therapeutics. His academic credentials include: ePG in AI and ML from Indian Institute of Information Technology, Bangalore (2023) PhD in Biological Sciences from Indian Institute of Science Education and Research, Bhopal (2021) MS in Life Sciences from School of Life Sciences, DAVV, Indore (2009) BS in Biotechnology from University of Rajasthan, Jaipur (2006) Dr. Mahla's research focuses on antigen-specific B cell responses in EBV and HSV infections, with emphasis on characterizing neutralizing monoclonal antibodies and cell-to-cell communication mechanisms in skin immunity. He pioneers the application of deep learning to VDJ sequencing and gene expression data to decode B cell receptor evolution during viral neutralization, creating synergies between wet-lab immunology and artificial intelligence. As an Editor for Expert Reviews in Molecular Medicine , he contributes to scholarly discourse in molecular virology. His current projects center on discovering and validating EBV-specific monoclonal antibodies for therapeutic development, with implications for vaccine design against persistent viral infections.

Dean R MaddenView profile

Professor

• Ion channels
• Molecular structure
• Glutamate receptors
• +5 more

Dean R Madden, PhD serves as Professor of Biochemistry and Cell Biology at Dartmouth College's Geisel School of Medicine. He holds significant leadership positions including Vice Provost for Research, Director of the Dartmouth Institute for Biomolecular Targeting, and Director of the Dartmouth Cystic Fibrosis Research Center (DartCF). His academic journey began with an A.B. in Physics from Harvard (1985) followed by a Ph.D. in Biophysics from Harvard (1992). Dr. Madden's research focuses on understanding ion channels and transporters at the molecular level, particularly AMPA-receptor subfamily of glutamate receptors and the cystic fibrosis transmembrane conductance regulator (CFTR). His work bridges structural biology, biophysics, and translational medicine with applications in neurological disorders and cystic fibrosis treatment. He employs diverse methodologies including X-ray crystallography, NMR, fluorescence spectroscopy, and computational modeling. His publication record demonstrates consistent contributions to understanding protein-ligand interactions, particularly in the context of PDZ domains and CFTR-related mechanisms. Recent work shows increasing focus on bacterial virulence factors in cystic fibrosis, particularly Pseudomonas aeruginosa and its Cif protein. His research integrates structural insights with physiological implications, creating a strong foundation for therapeutic development. Dr. Madden actively mentors early-career faculty through the COBRE Institute for Biomolecular Targeting and leads GrantGPS, a college-wide initiative supporting faculty scholarship. He has served as Chair of the MCB Graduate Program and contributed to Dartmouth's Strategic Planning for Graduate Education and Geisel Curriculum Reform initiatives. His laboratory maintains robust NIH funding from NIDDK, NIGMS, and NHLBI, with past support from NIAID and the Cystic Fibrosis Foundation. As course director for BIOC101 (Molecular Information in Biological Systems), he continues to contribute to medical education while directing two major program-project grants.

• Microbiology
• Genomics
• Phage Biology
• +2 more

Alex Broussard serves as an Additional Instructor at Durham Technical Community College within the SEA-PHAGES (Science Education Alliance-Phage Hunters Advancing Genomics and Evolutionary Science) program, a national initiative integrating undergraduate research into biology curricula through bacteriophage discovery and genomic analysis. Research interests center on experimental and computational approaches in microbial systems, with emphasis on: Phage isolation and characterization Bacterial host-pathogen interactions Genomic annotation workflows Undergraduate research pedagogy Evolutionary microbiology Computational biology education Co-instructing BIO111 sections with Primary Instructor Marie Fogarty, Broussard guides freshman students through hands-on phage discovery using Gordonia rubripertincta as host organism. Each 14-15 student cohort engages in 6-7 weekly hours of laboratory and bioinformatics work across 2-3 sessions, conducting wet-lab experiments and genomic analyses within the SEA-PHAGES framework. As part of this HHMI-funded network connecting over 100 institutions, Broussard contributes to collaborative science education efforts while implementing standardized phage genomics protocols that advance both pedagogical innovation and microbial evolutionary research.

Shibiao WanView profile

Assistant Professor

• Machine Learning
• Bioinformatics
• Computational Biology
• +14 more

Dr. Shibiao Wan serves as Assistant Professor in the Department of Genetics, Cell Biology and Anatomy at University of Nebraska Medical Center (UNMC), with a courtesy appointment in Biostatistics. He is Co-Director for the Bioinformatics and Systems Biology (BISB) PhD Program and Assistant Director for the Bioinformatics and Systems Biology Core. With over 14 years of experience in machine learning and bioinformatics, Dr. Wan leads an active research program developing computational methods for biomedical data analysis. Dr. Wan's research spans computational biology and biomedical informatics with focus on single-cell analysis, multi-omics integration, spatial transcriptomics, and cancer research. His laboratory develops AI and machine learning approaches to analyze genomics, transcriptomics, epigenetics, proteomics, metabolomics, and medical imaging data. Key contributions include methods for protein subcellular localization prediction, cancer subtyping, and multi-omics integration for precision medicine applications. His recent publications show a strong trend toward multi-modal data integration for disease diagnosis and subtyping, particularly in cancer (medulloblastoma, leukemia, lung cancer) and neurodegenerative disorders (Alzheimer's disease). His laboratory has developed numerous bioinformatics tools including SHARP for single-cell RNA-seq analysis, RaMBat for medulloblastoma classification, RanBALL for leukemia subtyping, and WIMOAD for Alzheimer's diagnosis. Dr. Wan has received significant recognition including the Springer Nature Editor of Distinction Award (2025), UNMC New Investigator Award (2024), FIRST Award from Nebraska EPSCoR (2023), and the Outstanding Young Alumni Award from HK PolyU (2022). He was named among the top 1% reviewers globally by Clarivate in both 'Cross-Field' and 'Biology and Biochemistry' categories (2019). As Co-Director of the BISB PhD Program, Dr. Wan actively mentors graduate students in bioinformatics and computational biology. His laboratory comprises a multidisciplinary team working at the intersection of computer science, statistics, and biomedical research. Dr. Wan serves as Editor-in-Chief for Current Proteomics and holds editorial positions with numerous high-impact journals including Briefings in Functional Genomics, BMC Bioinformatics, and Frontiers journals. The Wan Lab at UNMC focuses on machine learning and bioinformatics (MLAB), developing computational methods to unravel molecular biological systems using heterogeneous biomedical data. The lab collaborates extensively with scientists in cancer biology, metabolism, immunology, pathology, and developmental biology to translate computational findings into biological insights and potential clinical applications.

• R-loop Biology
• Epigenetics
• DNA Methylation
• +4 more

Frédéric Chédin is a Professor in the Department of Molecular and Cellular Biology at the University of California Davis, College of Biological Sciences. He has held continuous faculty positions at UC Davis since 2004, progressing from Assistant Professor (2004-2010) to Associate Professor (2010-2015), and currently serving as full Professor (2015-present). His research focuses on R-loop biology, DNA methylation, and epigenetic regulation. Chédin's laboratory investigates how RNA:DNA hybrids form, persist, and impact genome stability, with particular emphasis on their roles in transcription, chromatin organization, and disease mechanisms. His work has established foundational methodologies for R-loop detection and mapping, including critical assessments of common techniques like the S9.6 antibody. Chédin's publication record demonstrates consistent leadership in R-loop research, with numerous high-impact papers in journals like PNAS , Nature Communications , and Molecular Cell . His recent work explores protein-mediated R-loop stabilization, R-loop classification systems, and connections between R-loops and topological stress management. Director of NIH T32 Predoctoral Training Program in MCB (2020-present) Co-Director of NIH T32 Program (2019-2020) Chair of Integrative Genetics and Genomics (2015-2019) His laboratory trains numerous graduate students and postdoctoral researchers, with frequent collaborators including Stella Hartono and Lionel Sanz appearing as first authors on key publications. Chédin maintains active service roles in graduate education and program leadership at UC Davis.

Jill JohnsenView profile

Professor

• Hematology
• Blood Disorders
• Genetics of Clotting Factors
• +4 more

Dr. Jill Johnsen is an Academic Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine. She serves as faculty at both the Institute for Stem Cell & Regenerative Medicine and the Center for Cardiovascular Biology at UW. Dr. Johnsen is also affiliated with the Washington Center for Bleeding Disorders, where she practices clinically. Education: M.D. from Case Western Reserve University Residency in Internal Medicine at University Hospitals of Cleveland Fellowship in Hematology/Oncology at University of Michigan Dr. Johnsen is a physician scientist specializing in classical hematology with a focus on von Willebrand disease, hemophilia, and blood group genetics. Her research program aims to improve diagnosis and care of patients with blood disorders through advancement of our understanding of the underlying biology. She leverages new technologies including targeted and whole genome next generation DNA sequencing, multi-omics, and long-read sequencing to study the genetics of clotting factors and blood groups, with particular emphasis on how bleeding uniquely impacts females. Analysis of Dr. Johnsen's recent publications reveals a strong focus on von Willebrand disease genetics, hemophilia research, and blood group antigen studies. Her work spans basic science investigations of coagulation factor biology to clinical studies examining diagnosis and treatment approaches. A consistent theme is the application of genomic technologies to understand bleeding disorders across diverse populations. Professional Activities: Active participant in the My Life, Our Future hemophilia genotyping initiative Contributor to NHLBI Exome Sequencing Project and TOPMed Program Regular presenter at hematology conferences including ISTH and ASH

Yazan AlwarawrahView profile

Assistant Professor

• Immunometabolism
• T cell biology
• Obesity-related immune dysfunction
• +4 more

Dr. Yazan Alwarawrah is an Assistant Professor of Pediatrics at the University of North Carolina at Chapel Hill School of Medicine, specializing in Pediatric Endocrinology. His research focuses on the intersection of immunology and metabolism, with particular emphasis on how obesity affects immune function and the development of metabolic interventions for immune-related pathologies. Undergraduate: Al Al-Bayt University, Mafraq, Jordan Master of Science: Yarmouk University, Irbid, Jordan Doctor of Philosophy: Pharmacology, Duke University Dr. Alwarawrah's primary research interests center on immunometabolism, particularly how metabolic pathways regulate immune cell function in obesity and disease states. His work investigates T cell metabolism in the context of obesity-associated immune dysfunction, with specific focus on protective immunity against influenza. He also studies the role of Immunity Related GTPase I (Irgm1) in regulating T cell metabolism and function, and explores metabolic engineering approaches to enhance chimeric antigen receptor (CAR) T cell persistence in tumor microenvironments. His diverse scientific background spans molecular biology, bioinformatics, pharmacology, and immunology. Analysis of Dr. Alwarawrah's publication record reveals a strong focus on the intersection of metabolism and immunity, particularly in obesity contexts. His work spans fundamental mechanisms of immune cell metabolism to translational applications in infectious disease, cancer, and autoimmune conditions. Key themes include T cell metabolic dysfunction in obesity, macrophage metabolism, and pharmacological targeting of metabolic pathways for therapeutic benefit. His research employs diverse approaches including diet-induced obesity mouse models, metabolic and flow cytometric analyses, and pharmacological interventions. Dr. Alwarawrah's research program bridges basic science and clinical applications, with implications for treating obesity-associated pathologies, cancer, and autoimmune diseases through metabolic interventions. His work on T cell metabolism in obesity has particular relevance for understanding impaired immune responses in metabolic disease states. While specific grant information isn't detailed in the provided materials, his research trajectory suggests involvement in NIH-funded projects related to immunometabolism and obesity.

Alison CupplesView profile

Professor

• Environmental Microbiology
• Bioremediation
• Contaminant Biodegradation
• +5 more

Dr. Alison Cupples is a Professor in the Department of Civil and Environmental Engineering at Michigan State University's College of Engineering. Her research focuses on Environmental Microbiology , specifically applying microbiology to understand and treat soil and water contamination through bioremediation techniques. Ph.D., Environmental Engineering and Science, Stanford University (2003) M.S., Natural Resources and Environmental Sciences, University of Illinois (1999) B.S., Environmental Sciences, University of East Anglia, England (1997) Her work centers on identifying microorganisms and functional genes responsible for biodegrading traditional contaminants (chlorinated solvents, BTEX, MTBE, RDX, 11,4-dioxane) and emerging contaminants (antimicrobials, pharmaceuticals, personal care products). She also specializes in molecular methods like quantitative PCR , LAMP , stable isotope probing , and high-throughput sequencing to analyze microbial communities. Recent articles highlight her expertise in 1,4-dioxane biodegradation , propane monooxygenase systems , and metagenomic analysis of contaminated sites. Her team has developed novel microbial cultures for degrading persistent pollutants and pioneered on-site detection tools for dechlorinating bacteria. Scientific Awards Service Award, ASEE Division of Environmental Engineering (2021) Withrow Teaching Excellence Award (2015-2016) Lilly Teaching Fellow, MSU (2011-2012) Excellence in Review Award, Environmental Science & Technology (2011) USDA-ARS Superior Research Awards (2005, 2004) Dr. Cupples has mentored 12 PhD/MS students and secured funding from NSF, USDA, and SERDP. Her outreach includes directing laboratory programs for the High School Engineering Institute and Wireless Integrated MicroSystems for TEENS initiatives.

Hong YuView profile

Adjunct Professor

• Computational Biology
• Bioinformatics
• Information Retrieval
• +3 more

Hong Yu is an Adjunct Professor at the University of Massachusetts Amherst, affiliated with the Center for Intelligent Information Retrieval and the Biomedical Informatics Natural Language Processing (BioNLP) Laboratory. Her research focuses on computational biology, bioinformatics, and biomedical applications of information retrieval, natural language processing, and human-computer interaction. She has developed systems like AskHERMES (a biomedical Q&A tool) and NoteAid (to aid patient comprehension of medical records). Education includes a PhD in Biomedical Informatics from Columbia University, M.Ph. in Physiology and Cellular Biophysics, and degrees in Physiology and Biomedical Engineering from institutions in China. She has led NIH-funded projects and serves on the editorial board of the Journal of Biomedical Informatics. Research awards include the NLM predoctoral training grant and recognition as one of six 'Star Trainees' for NLM's 175th anniversary. Her work has been featured in Science, Nature, and the Pulitzer-winning Milwaukee Journal Sentinel. Current interests emphasize privacy in geospatial data, ethical AI, and reimagining GIScience education. Grants: Multiple NIH-funded projects. Labs: Center for Intelligent Information Retrieval, BioNLP Lab. Service: Co-chair of biomedical NLP sections at major conferences.

• Protein Synthesis Mechanisms
• Translation Elongation/Termination
• Systems Biology
• +3 more

Professor Ian Stansfield is a Personal Chair in the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen. He holds a BSc (Hons) in Microbiology and a PhD in Biochemistry from the University of Sheffield. His research focuses on protein synthesis mechanisms in eukaryotes, translation elongation/termination, and systems biology approaches to model these processes. Collaborations with Prof M.Carmen Romano integrate mathematical modeling to study translation dynamics and synthetic biology applications. Teaching roles include coordinating MSc programs in Biotechnology, Bioinformatics, and Biobusiness, as well as undergraduate modules in Microbiology and Molecular Biology. He led successful iGEM teams, achieving Gold and Silver medals for developing diagnostic systems for neglected tropical diseases using synthetic biology. Key research areas include translational stress management during protein expression, bioinformatic analysis of mRNA sequences, and optimizing yeast as a protein expression system. Notable grants include BBSRC funding for synthetic gene circuits and systems biology analysis of translation termination factors. Scientific awards include iGEM Gold Medals (2009, 2014) and a Silver Medal (2010), with the 2014 entry winning Best Health and Medicine and Best Measurement Device awards. His work spans over 40 peer-reviewed publications, exploring topics from ribosomal pausing to tRNA properties in codon usage. Leadership roles include Director of Research in his School, overseeing research strategy and NHS partnerships. External roles include membership on BBSRC panels and the BioProNet management board, reflecting his influence in biotechnology and bioenergy sectors.

Christopher F BarnesView profile

Associate Professor

• Synthetic Aperture Radar (SAR)
• Signal Processing
• Data Mining
• +5 more

Christopher F. Barnes is an Associate Professor in the School of Electrical and Computer Engineering at the Georgia Institute of Technology, with adjunct status as a Principal Research Engineer at the Georgia Tech Research Institute (GTRI). He holds a Ph.D. from Brigham Young University (1989) and has over 27 years of experience in radar signal processing, software engineering, and applied research. His research focuses on synthetic aperture radar (SAR) analysis, data mining, and image/video-driven technologies with applications in remote sensing, medical imaging, and seismology. Dr. Barnes' expertise includes radar imaging algorithms, software architectures for radar systems, and object-oriented programming. He pioneered methods for three-dimensional coherently fused SAR imaging and developed image-driven systems for hurricane damage assessments and bioinformatics. His work in video tracking and content-based search leverages residual vector quantization and machine vision techniques. Notable achievements include the Georgia Tech Outstanding Professional Education Award (2009) and an Interdisciplinary Research Initiative Award (2006). His contributions span over 140 publications and one patent, with research supported by defense and academic collaborations. Dr. Barnes teaches SAR at professional and graduate levels and advises research in video-driven data mining and medical imaging applications. His current projects explore AI-driven SAR analysis and advanced radar system architectures.